Patents for C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749) |
---|
05/12/2009 | US7531560 Anti-cytokine heterocyclic compounds |
05/12/2009 | US7531559 Fungicidal 1,2,3 triazole derivatives |
05/12/2009 | CA2278553C Phenylsulfonylureas, processes for their preparation, and their use as herbicides and plant growth regulators |
05/07/2009 | WO2009057676A1 Azo compound, and dye-containing polarizing film comprising the same |
05/07/2009 | WO2009056692A2 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors |
05/07/2009 | WO2009055863A1 Desferrioxamine conjugates, derivatives and analogues |
05/07/2009 | WO2009018065A3 Novel glucokinase activators and methods of using same |
05/07/2009 | US20090118517 Purification process for anastrozole intermediate |
05/07/2009 | CA2703934A1 Azo compound, and dye-containing polarizing film comprising the same |
05/07/2009 | CA2703909A1 P2x3, receptor antagonists for treatment of pain |
05/07/2009 | CA2695628A1 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors |
05/06/2009 | EP2054383A2 Novel compounds as antagonists or inverse agonists at opioid receptors |
05/06/2009 | EP1465861B1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
04/30/2009 | US20090111996 N-(2-aminophenyl)-4-((5,6-dimethoxy-2H-indazol-2-yl)methyl)benzamide, as a solid or liquid formulation adapted for oral administration; antiprolilferative agent |
04/30/2009 | US20090111863 Compounds, Compositions and Methods for the Treatment of Beta-Amyloid Diseases and Synucleinopathies |
04/30/2009 | US20090111862 Compound |
04/30/2009 | US20090111857 1,2,4-triazole ether derivatives as modulators of mglur5 |
04/30/2009 | US20090111823 Aminopyridine derivatives as modulators of mglur5 |
04/30/2009 | US20090111822 1,2,3-triazole pyrrolidine derivatives as modulators of mglur5 |
04/30/2009 | US20090111821 Amino 1,2,4-triazole derivatives as modulators of mglur5 |
04/30/2009 | US20090111129 Methods and Kits for Detecting Fungal Infection |
04/30/2009 | US20090106915 Coloring hair non-oxidatively with pyridine dyes complexed with iron (II) ormanganese; 2-(Methyl-[2,2';6'2'']terpyridine-4'yl-amino)-ethanol ligand;no additional dye precursor needed, nor a pretreatment or a swelling agents;simplification |
04/29/2009 | EP2051707A2 Inhibitors of plasma kallikrein |
04/29/2009 | CN101417964A Use of compounds for the elevation of pyruvate dehydrogenase activity |
04/29/2009 | CN100482666C Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics |
04/28/2009 | US7524875 Polyether with glycerol backbone; capable of being labeled |
04/28/2009 | US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis |
04/28/2009 | US7524863 Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors |
04/28/2009 | US7524844 Dipeptidyl peptidase IV inhibitors, process for their preparation and compositions containing them |
04/28/2009 | CA2525437C Benzamide inhibitors of the p2x7 receptor |
04/23/2009 | WO2009052078A1 Ccr10 antagonists |
04/23/2009 | WO2007019660A3 Azole compounds used as tuberculostatic and leishmanicide agents |
04/23/2009 | US20090105485 Histone deacetylase inhibitors |
04/23/2009 | US20090105279 Tetrahydrofuro[2,3-b]furyl carbamates containing an (oxy)hydrazide group; these compounds target the HIV protease in both wild type and mutant strains of HIV. |
04/23/2009 | US20090105253 Triazole Derivative and Use Thereof |
04/23/2009 | US20090105230 Anti-inflammatory medicaments |
04/23/2009 | US20090104151 Smac mimetic dimers and trimers useful as anti-cancer agents |
04/23/2009 | CA2702469A1 Ccr10 antagonists |
04/22/2009 | CN101415691A Triazole derivative |
04/22/2009 | CN100481571C Luminescent element material and luminescent element comprising the same |
04/21/2009 | US7521470 Factor Xa inhibitors |
04/16/2009 | WO2009049180A2 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels |
04/16/2009 | WO2009047514A1 [1,2,4]triazolo[1,5-a]pyridine and [1,2,4]triazolo[1,5-c]pyrimidine compounds and their use |
04/16/2009 | WO2009046841A2 Piperidine and piperazine derivatives for treating tumours |
04/16/2009 | WO2007005058A3 Monoazole ligand platinum analogs |
04/16/2009 | WO2003082205A3 Compounds and methods |
04/16/2009 | US20090099233 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels |
04/16/2009 | CA2701946A1 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels |
04/16/2009 | CA2701519A1 Piperidine and piperazine derivatives |
04/15/2009 | EP2046762A2 Triazolyl phenyl benzenesulfonamides |
04/15/2009 | EP2046733A1 Process for the preparation of epsilon-alkoxycarbonyllysines and their analogues |
04/14/2009 | US7517998 Benzothiazole or benzothiazine derivative of dipyrido(2,3;b:2',3'-e) diazepin-6-one; viricide against human t-cell leukemia/lymphoma virus |
04/14/2009 | US7517988 N-hydroxy-4-[2-(benzofuran-2-ylcarbonylamino)ethylsulfonyl]-benzamide; hepatitis C; inhibitors of histone deacetylase |
04/14/2009 | CA2380980C Mutilin derivatives and their use as antibacterials |
04/09/2009 | WO2009044707A1 Nitrotriazole derivative and method for producing compound using the same |
04/09/2009 | WO2009043117A1 Novel aryl potassium channel blockers and uses thereof |
04/09/2009 | WO2009019472A4 1, 2, 4 -triazole derivatives as serotonergic modulators |
04/09/2009 | WO2008145563A3 Process for preparing triazolones |
04/09/2009 | US20090093524 Compounds and methods for modulating fxr |
04/09/2009 | US20090091234 Room temperature molten salt and display element |
04/09/2009 | CA2701579A1 Novel aryl potassium channel blockers and uses thereof |
04/08/2009 | EP2044018A1 Substituted n-bicyclicalkyl bicyclic carboxyamide compounds |
04/08/2009 | EP1877364B1 Phenylacetylene derivatives having mglur5 receptor affinity |
04/08/2009 | EP1442026B1 Triazole derivatives as cyclooxygenase (cox) inhibitors |
04/08/2009 | CN101405275A Triazolone derivative |
04/08/2009 | CN101402613A Substituted phenoxy oxygen alkylamine triazole alcohol antimycotic compounds and method of preparing the same |
04/08/2009 | CN100475787C Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents |
04/07/2009 | US7514475 Benzylamine analogues |
04/07/2009 | US7514459 Gamma-secretase inhibitors |
04/07/2009 | US7514457 Substituted aryloxymethyl bicyclicmethyl acetamide compounds |
04/02/2009 | WO2009021747A3 Treatment of duchenne muscular dystrophy |
04/02/2009 | WO2005057171A3 Protein-protein interaction antagonist screening libraries based upon 1,4-disubstituted naphthalenes and related scaffolds |
04/02/2009 | US20090088570 Organic electroluminescent device |
04/02/2009 | US20090087376 Heterocyclic Dye Compounds For In Vivo Imaging And Diagnosis Of Alzheimer's Disease |
04/01/2009 | EP1646661B1 Living radical polymerization initiator comprising a functional group capable of reacting with polypeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drung obtained therefrom |
04/01/2009 | EP1521744B1 Arylsulphonamide derivatives and use thereof as b1 bradykinin receptor antagonists |
04/01/2009 | CN101400660A Triazole derivative or salt thereof |
04/01/2009 | CN100473648C 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors |
03/31/2009 | US7511152 6-(trifluoromethyl)-3,9,10,11-tetrahydro-8,10a-methanocyclohepta[1,2]indeno[4,5-d][1,2,3]triazol-7(8H)-one; uterine fibroid disease, hot flashes, urogenital disorders, inflammation; improved metabolic profile |
03/31/2009 | US7511067 3-hydroxymethyl-4-hydroxy-phenyl-derivatives for the treatment of respiratory diseases |
03/31/2009 | US7511061 Triazoles as farnesyl transferase inhibitors |
03/31/2009 | US7511042 1-[5-(5-tert-Butyl-2-methoxy-3-methylsulfamoyl-phenylcarbamoyl)-2-methyl-phenyl]-1H-1,2,3-triazole-4-carboxylic acid (2,2-dimethyl-propyl)-amide; small molecule cytokine inhibitor; optimized efficacy, pharmacokinetic; antiinflammatory agent, osteoarthritis, asthma, gastrointestinal, respiratory disorder |
03/31/2009 | US7511034 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants |
03/26/2009 | WO2009039257A1 Methods for production of 1,2,4-triazol-3-one |
03/26/2009 | WO2009039255A1 Methods for production of 1,2,4-triazol-3-one |
03/26/2009 | WO2009038847A1 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides |
03/26/2009 | WO2009038784A1 Triazole fused heteroaryl compounds as p38 kinase inhibitors |
03/26/2009 | WO2008094617A3 Crystalline forms of deferasirox |
03/26/2009 | WO2008007211A8 Substituted n-bicyclicalkyl bicyclic carboxyamide compounds |
03/26/2009 | US20090082413 Deuterium-enriched letrozole |
03/26/2009 | US20090082412 Deuterium-enriched deferasirox |
03/26/2009 | US20090079343 Organic electroluminescent device |
03/26/2009 | CA2691031A1 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides |
03/25/2009 | EP2038262A2 Triazole compounds that modulate hsp90 activity |
03/25/2009 | EP1991514A4 Novel anthracene derivative and organic electronic device using the same |
03/25/2009 | CN101391986A Fluorine triazole ethers derivates and salt with antimicrobial activity, preparation method and medical use |
03/25/2009 | CN101391985A Triazole onium compound with antimicrobial activity, preparation method and medical use |
03/24/2009 | US7507832 Triazole PPAR modulators |
03/24/2009 | US7507757 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
03/19/2009 | WO2009015446A3 Triazole derivatives as viral replication inhibitors |